A growing body of research is exploring immunotherapy as a way to treat addiction and prevent deadly overdoses.
Similar to a flu shot, a fentanyl vaccine aims to work by prompting an immune system response. In the new study, researchers made their vaccine using a deactivated diphtheria protein already used in multiple FDA-approved shots, a molecule similar to fentanyl, a molecular bridge to link the two together, and a compound known to boost immune response in other vaccines The idea is to train the body to recognize fentanyl as a threat and create antibodies against the drug.
Across all of their tests, the researchers found that their vaccine worked.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experimental cancer vaccine shows promising results in animal studies, NIH researchers findThe study found the vaccine boosted the number of cytotoxic T cells capable of infiltrating and attacking tumor cells.
Read more »
Fentanyl Vaccine Breakthrough – Potential “Game Changer” for Opioid EpidemicStudy suggests new vaccine could prevent deadly opioid from entering the brain. A new vaccine has been developed that targets the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.” The breakthrough discovery could have major impl
Read more »
Fentanyl 'vaccine' may have been discovered, researchers sayFentanyl is 50 times stronger than heroin and 100 times stronger than morphine.
Read more »
How Maya Deren Became the Symbol and Champion of American Experimental FilmThe filmmaker Maya Deren nearly single-handedly put experimental cinema on the American cultural map. Then, just as quickly, she fell out of that world, never to return in her too-brief lifetime.
Read more »
2023 BMW X1 Is Practical, Not ExperimentalThere's nothing radical about the new version of BMW's smallest SUV, but it offers a lot for a smallish price.
Read more »
Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials | CNNAn experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.
Read more »